Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer (Q28247712)

2

0 references

S Zazo

3

0 references

I Tusquets

4

0 references

J Ferrer-Lozano

5

0 references

S Menendez

6

0 references

P Eroles

7

0 references

C Chamizo

8

0 references

S Servitja

9

0 references

N Ramírez-Merino

10

0 references

F Lobo

11

0 references

B Bellosillo

12

0 references

J M Corominas

13

0 references

J Yelamos

14

0 references

S Serrano

15

0 references

A Lluch

16

0 references

A Rovira

17

0 references

J Albanell

Poly(ADP-ribose): novel functions for an old molecule

18

0 references

language of work or name

English

0 references

publication date

May 2012

0 references

published in

Annals of Oncology

0 references

volume

23

0 references

issue

5

0 references

page(s)

1156-64

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Making the best of PARP inhibitors in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Basal-like breast cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Iniparib plus chemotherapy in metastatic triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Proliferation marker Ki-67 in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Multispectral imaging and pathology: seeing and doing more

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Poly(ADP-ribose) polymerase inhibition down-regulates expression of metastasis-related genes in CT26 colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361

Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR361